Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma

References

• Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.
   PubMed Web of Science ®Google Scholar
• Lassen P, Primdahl H, Johansen J, et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol. 2014;113:310–316.
   PubMed Web of Science ®Google Scholar
• Svahn MF, Munk C, Nielsen TS, et al. Trends in all-cause five-year mortality after head and neck cancers diagnosed over a period of 33 years. Focus on estimated degree of association with human papillomavirus. Acta Oncol. 2016;55:1084–1090.
   PubMed Web of Science ®Google Scholar
• Bentzen J, Toustrup K, Eriksen JG, et al. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol. 2015;54:1001–1007.
   PubMed Web of Science ®Google Scholar
• Riesterer O, Milas L, Ang KK. Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy. J Clin Oncol. 2007;25:4075–4083.
   PubMed Web of Science ®Google Scholar
• Kang H, Kiess A, Chung CH. Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol. 2015;12:11–26.
   PubMed Web of Science ®Google Scholar
• Toustrup K, Sorensen BS, Metwally MA, et al. Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials. Acta Oncol. 2016;55:1091–1098.
   PubMed Web of Science ®Google Scholar
• Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441–446.
   PubMed Web of Science ®Google Scholar
• Hatt M, Tixier F, Pierce L, et al. Characterization of PET/CT images using texture analysis: the past, the present any future? Eur J Nucl Med Mol Imaging. 2017;44:151–165.
   PubMed Web of Science ®Google Scholar
• Yip SSF, Aerts HJWL. Applications and limitations of radiomics. Phys Med Biol. 2016;61:150–166.
   PubMed Web of Science ®Google Scholar
• Wong AJ, Kanwar A, Mohamed AS, et al. Radiomics in head and neck cancer: from exploration to application. Transl Cancer Res. 2016;5:371–382.
   PubMed Web of Science ®Google Scholar
• Bogowicz M, Riesterer O, Ikenberg K, et al. CT radiomics predicts HPV status and local tumor control after definitive radiochemotherapy in head and neck squamous cell carcinoma. Int J Rad Onc Biol Phys. Forthcoming 2017.
   PubMed Web of Science ®Google Scholar
• Aerts HJWL, Velazquez ER, Leijenaar RTH, etet al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.
   PubMed Web of Science ®Google Scholar
• Parmar C, Leijenaar RTH, Grossmann P, et al. Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep. 2015;5:11004.
   PubMed Web of Science ®Google Scholar
• Leijenaar RTH, Carvalho S, Hoebers FJ, et al. External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol. 2015;54:1423–1429.
   PubMed Web of Science ®Google Scholar
• Jansen JF, Lu Y, Gupta G, et al. Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer. WJR. 2016;8:90–97.
   Web of Science ®Google Scholar
• Shukla-Dave A, Lee NY, Jansen JF, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys. 2012;82:1837–1844.
   PubMed Web of Science ®Google Scholar
• Paidpally V, Chirindel A, Lam S, et al. FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med. 2012;4:633–647.
   PubMedGoogle Scholar
• Vallières M, Kay-Rivest E, Perrin LJ, et al. Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. arXiv:1703.08516.
   Google Scholar
• De Schutter H, Landuyt W, Verbeken E, et al. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. BMC Cancer. 2005;5:42.
   PubMed Web of Science ®Google Scholar
• Nesteruk M, Lang S, Veit-Haibach P, et al. Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma. Radiother Oncol. 2015;117:125–131.
   PubMed Web of Science ®Google Scholar
• Leijenaar RT, Carvalho S, Velazquez ER, et al. Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol. 2013;52:1391–1397.
   PubMed Web of Science ®Google Scholar
• Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84:5–10.
   PubMed Web of Science ®Google Scholar